NIDCD Research Grants (R Series)

NIDCD R21 Exploratory/Developmental Research Grant

Supports early exploratory methods and technologies for communication science in the United States.

The NIDCD R21 Exploratory/Developmental Research Grant supports early-stage and high-risk/high-reward research within the National Institute on Deafness and Other Communication Disorders' seven mission areas: hearing, balance, taste, smell, voice, speech, and language. NIDCD is a component of the National Institutes of Health under the U.S. Department of Health and Human Services, with a typical annual budget near $540 million. The R21 mechanism is designed for conceptually novel investigations where preliminary data may be limited and scientific risk is elevated, enabling investigators to develop new methodologies, test innovative hypotheses, or explore transformative research directions before committing to a full R01.

NIDCD administers two R21 tracks: the standard R21 Exploratory/Developmental Grant, open to the same broad range of domestic research institutions eligible for R01 awards, and the NIDCD Early Career Research Award (R21), a institute-specific variant targeting scientists who are establishing their independent research programs in communication-related disciplines. Universities, medical schools, hospitals, research institutes, for-profit organizations, and government institutions may all apply; individual investigators without institutional affiliation are not eligible. New R21 applications are due February 16, June 16, and October 16 each year under standard NIH receipt-date cycles.

Successful R21 applicants typically frame their projects around clear innovation potential and describe how the exploratory work will generate the feasibility evidence needed for subsequent R01 submissions. NIDCD program officers can advise on topical alignment prior to application. As with all NIDCD grants, work must address the institute's mission areas, and recent reissuances of related FOAs in 2025 reflect updated agency priorities under the current NIH funding environment, making a careful review of the applicable funding opportunity announcement essential before submission.